Clinical Studies
Phase 2 Science Dossier
Phase 2 Product Documents
Research Milestones
Phase 2 Research Studies
- - Study 1 A Randomized, Double-Blind, Placebo-Controlled Trial of a New Weight-Reducing Agent of Natural Origin
- - Study 2 A Dietary Supplement Containing Standardized Phaseolus Vulgaris Extract Influences Body Composition of Overweight Men and Women
- - Study 3 Investigation of an Amylase Inhibitor on Human Glucose Absorption After Starch Consumption
- - Study 4 Evaluation of the Generally Recognized as Safe (GRAS) Status of Phase 2 White Bean (Phaseolus Vulgaris) Extract
- - Study 5 Blocking Carbohydrate Absorption and Weight Loss: A Clinical Trial Using Phase 2 Brand Proprietary Fractionated Bean Extract
- - Study 6 Reduction in Body Weight with a Starch Blocking Diet Aid: StarchAway Comparison with Placebo,
- - Study 7 Blocking Carbohydrate Absorption and Weight Loss: A Clinical Trial Using a Proprietary Fractionated White Bean Extract
- - Study 8 The Effect of TheraSlim [with Phase 2] on Weight, Body Composition, and Select Laboratory Parameters in Adults with Overweight and Mild-Moderate Obesity,
- - Study 9 The Anti-Obesity Effect and the Safety of Taking Phaseolamin™ 1600 Diet
- - Study 10 Random Multi-Center Evaluation to Test the Efficacy of Phaseolus Vulgaris [PreCarb/Phase 2] in Obese and Overweight Subjects
- - Study 11 A Novel Method of Lowering the Glycemic Index of White Bread Using a Proprietary White Bean Extract
- - Study 12 A Novel Method of Lowering the Glycemic Index of White Bread Using a Proprietary White Bean Extract
- - Study 13 Study to Determine the Stability of Phase 2/StarchLite in Instant Mashed Potatoes and Develop a Method for Monitoring Alpha-Amylase Inhibiting Activity
- - Study 14 Study to Assess the Efficacy of Phase 2/StarchLite in Inhibiting the Human Salivary Alpha Amylase in Chewing Gum
- - Study 15 Effects of Combination of Functional Food Materials on Body Weight, Body Fat Percentage, Serum Triglycerides and Blood Glucose
- - Study 16 The Nutraceutical Role of Phaseolus Vulgaris Apha-Amylase Inhibitor
- - Study 17 Weight Loss with a Low-Carbohydrate, Mediterranean, or Low-Fat Diet
- - Study 18 Alternations in Hepatic Glucose and Energy Metabolism as a Result of Calorie and Carbohydrate Restriction
©2011 Pharmachem. All rights reserved. | Contact Us | Sitemap | Legal International | Legal USA